Target intelligence / Profile preview

Cortical excitability modulation

Molecular classification
Other
01

Overview

"Cortical excitability modulation" does **not** refer to a specific molecule or receptor but rather describes the dynamic regulation of the balance between excitation and inhibition within regions of the cerebral cortex. This balance is crucial for processes such as neural plasticity, perceptual learning, sensory processing, and cognitive function. The main neurotransmitters involved in modulating cortical excitability are **GABA** (inhibitory) and **glutamate** (excitatory), which together shape the overall "excitatory state" in localized brain areas[1][2]. Changes in cortical excitability can be measured indirectly using techniques such as paired-pulse behavior assessments, magnetic resonance spectroscopy for GABA/glutamate levels, transcranial magnetic stimulation-induced phosphenes, or EEG alpha oscillations[1]. While interventions like neurofeedback or non-invasive brain stimulation can modulate baseline states of excitation to enhance learning outcomes or rehabilitation efficacy[1], "cortical excitability modulation" itself is not a discrete druggable entity but an emergent property arising from complex neuronal network interactions. In summary: "Cortical excitability modulation" is not a canonical molecular target but refers to physiological processes governing neural activity balance; it should not be listed as a therapeutic target molecule/receptor.

Other names
Cortical excitabilityModulation of cortical excitabilityExcitatory state of cortex
02

Biological functions

Neural plasticityLearning and memorySensory processingPerceptual learning
03

Disease associations

Neuropsychiatric disorders (e.g., migraine, synesthesia)Neurological rehabilitationOther (as a physiological process rather than a disease target)
04

Biomarkers

GABA and glutamate concentrationspaired-pulse behavioralpha oscillationsTMS phosphene thresholds

Beyond the preview

Go deeper on Cortical excitability modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortical excitability modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call